Stem cell transplant is safe, effective in myeloma: Global real-world study
A standard autologous hematopoietic stem cell transplant (AHSCT) safely and effectively prolongs survival and delays cancer progression in adults with multiple myeloma, a large, real-world international study indicates. Disease relapse was reported in 15.7% in the first year after the transplant, and patients lived a median of 7.5…